[1]
|
Shin, K.M., Kim, Y.H., Park, W.S., Kang, I., Ha, J., Choi, J.W., Park, H.J. and Lee, K.T. (2004) Inhibition of methanol extract from the fruits of Kochiascoparia on lipopolysaccharide-induced nitric oxide, prostaglandin E2, and tumor necrosis factor-alpha production from murine macrophage RAW 264.7 cells. Biological & Pharmaceutical Bulletin, 27, 538-543. http://dx.doi.org/10.1248/bpb.27.538
|
[2]
|
Kroncke, K.D., Fehsel, K. and Kolb-Bachofen, V. (1998) Inducible nitric oxide synthase in human diseases. Clinical & Experimental Immunology, 113, 147-156. http://dx.doi.org/10.1046/j.1365-2249.1998.00648.x
|
[3]
|
Laskin, D.L. and Pendino, K.J. (1995) Macrophages and inflammatory mediators in tissue injury. Annual Review of Pharmacology and Toxicology, 35, 655-677. http://dx.doi.org/10.1146/annurev.pa.35.040195.003255
|
[4]
|
Baeuerle, P.A. (1998) IκB-NF-κB structures: At the interface of inflammation control. Cell, 95, 729-731. http://dx.doi.org/10.1016/S0092-8674(00)81694-3
|
[5]
|
Brown, K., Gerberger, S., Carlson, L., Franzoso, G. and Siebenlist, U. (1995) Control of IκB-alpha proteolysis by site-specific, signal-induced phosphorylation. Science, 267, 1485-1488. http://dx.doi.org/10.1126/science.7878466
|
[6]
|
Didonato, J., Mercurio, F., Rosette, C., Wu, L.I., Suyang, H., Ghosh, S. and Karin, M. (1996) Mapping of the inducible IκB phosphorylation sites that signal its ubiquitination and degradation. Molecular and Cellular Biology, 4, 1295-1304.
|
[7]
|
Bonizzi, G. and Karin, M. (2004) The two NF-κB activation pathways and their role in innate and adaptive immunity. Trends in Immunology, 25, 280-288. http://dx.doi.org/10.1016/j.it.2004.03.008
|
[8]
|
Jirik, F.R., Podor, T.J., Hirano, T., Kishimoto, T., Loskutoff, D.J., Carson, D.A. and Lotz, M. (1989) Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells. Journal of Immunology, 142, 144-147.
|
[9]
|
Giuliano, F. and Warner, T.D. (2002) Origins of prostaglandin E2: Involvements of cyclooxygenase (COX)-1 and COX-2 in human and rat systems. Journal of Pharmacology and Experimental Therapeutics, 303, 1001-1006. http://dx.doi.org/10.1124/jpet.102.041244
|
[10]
|
Tak, P.P. and Firestein, G.S. (2001) NF-κB: A key role in inflammatory diseases. The Journal of Clinical Investigation, 107, 7-11. http://dx.doi.org/10.1172/JCI11830
|
[11]
|
Guha, M. and Mackman, N. (2001) LPS induction of gene expression in human monocytes. Cell Signal, 13, 85-94. http://dx.doi.org/10.1016/S0898-6568(00)00149-2
|
[12]
|
Subramanian, K., Selvakkumar, C., Vinaykumar, K.S., Goswami, N., Meenakshisundaram, S., Balakrishnan, A. and Lakshmi, B.S. (2009) Tackling multiple antibiotic resistance in enteropathogenic Escherichia coli (EPEC) clinical isolates: A diarylheptanoid from Alpiniaofficinarum shows promising antibacterial and immunomodulatory activity against EPEC and its lipopolysaccharide-induced inflammation. International Journal of Antimicrobial Agents, 33, 244-250. http://dx.doi.org/10.1016/j.ijantimicag.2008.08.032
|
[13]
|
Gayathri, B., Manjula, N., Vinaykumar, K.S., Lakshmi, B.S. and Balakrishnan, A. (2007) Pure compound from Boswelliaserrata extractexhibits anti-inflammatory property in human PBMCs and mousemacrophages through inhibition of TNF-α, IL-1α, NO and MAP kinases. International Immunopharmacology, 7, 473-482. http://dx.doi.org/10.1016/j.intimp.2006.12.003
|
[14]
|
Kim, J.Y., Jung, K.S. and Jeong, H.G. (2004) Suppressive effects of the kahweol and cafestolon cyclooxygenase-2 expression in macrophages. FEBS Letters, 569, 321-326. http://dx.doi.org/10.1016/j.febslet.2004.05.070
|
[15]
|
Rosalbasacca, C., Cuff, A. and Nancy, H.R. (1997) Mediators of inflammation. Current Opinion in Immunology, 9, 851-857.
|
[16]
|
Karin, M. and Ben Neriah, Y. (2000) Phosphorylation meets ubiquitination: the control of NF-κB activity. Annual Review of Immunology, 18, 621-663. http://dx.doi.org/10.1146/annurev.immunol.18.1.621
|
[17]
|
Epinat, J.C. and Gilmore, T.D. (1999) Diverse agents act at multiple levels to inhibit the Rel/NF-κB signal transduction pathway. Oncogene, 18, 6896-6909. http://dx.doi.org/10.1038/sj.onc.1203218
|
[18]
|
Madhavan, P.N., Supriya, M., Jessica, L.R., Ravikumar, A., Harikrishnan, N., Stanley, A.S. and Chithan, K. (2006) The flavonoid quercetin inhibits proinflammatory cytokine (tumor necrosis factor alpha) gene expression in normal peripheral blood mononuclear cells via modulation of the NF-κB System. Clinical and Vaccine Immunology, 13, 319-328. http://dx.doi.org/10.1128/CVI.13.3.319-328.2006
|
[19]
|
Jobin, C. (1999) Curcumin blocks cytokine-mediated NF-κB activation and proinflammatory gene expression by inhibiting inhibitory factor IκB kinase activity. Journal of Immunology, 163, 3474-3483.
|
[20]
|
Korhonen, R., Lahti, A., Kankaanranta, H. and Moilanen, E. (2005) Nitric oxide production and signaling in inflammation. Current Drug Targets: Inflammation & Allergy, 4, 471-479. http://dx.doi.org/10.2174/1568010054526359
|
[21]
|
Haefner, B. (2002) NF-κB: Arresting a major culprit in cancer. Drug Discovery Today, 7, 653-663. http://dx.doi.org/10.1016/S1359-6446(02)02309-7
|
[22]
|
Sizemore, N., Lerner, N., Dombrowski, N., Sakurai, H. and Stark, G.R. (2002) Distinct roles of the IkB kinase α and β subunits in liberating nuclear factor kB (NF-kB) from IkB and in phosphorylating the p65 subunit of NF-kB. Journal of Biological Chemistry, 277, 3863-3869. http://dx.doi.org/10.1074/jbc.M110572200
|
[23]
|
Gayathri, B., Lakshmi, J., Arun, B. and Baddireddi Subhadra, L. (2010) Molecular basis of the anti-inflammatory property exhibited by Cyclo-Pentano Phenanthrenol isolated from Lippianodiflora. Immunological Investigations, 39, 713-739. http://dx.doi.org/10.3109/08820139.2010.493190
|
[24]
|
Angela, S., Sumikotanaka, T., Hidetakamiyoshi, T., Masaki, S., Keisuke, K. and Takahisa, S. (1997) Pathophysiological role of nitric oxide in rat experimental colitis. International Journal of Immunopharmacology, 19, 669-676.
|
[25]
|
Tak, P.P. and Firestein, G.S. (2001) NF-κB: A key role in inflammatory diseases. Journal of Clinical Investigation, 107, 7-11. http://dx.doi.org/10.1172/JCI11830
|
[26]
|
Dixon, D.A. (2004) Dysregulated post-transcriptional control of COX-2 gene expression in cancer. Current Pharmaceutical Design, 10, 635-646. http://dx.doi.org/10.2174/1381612043453171
|